Janet Dillione
CIK 1489798 · Executive VP and GM Healthcare · last filed 2026-01-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$602.4K
Companies
2
Total Filings
71
Lifetime Open-Market Net
-$3.50M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRMD | Director | 68,926 | $8.74 | $602.4K | -$1.27M | 47 | 2026-01-27 |
| Nuance Communications, Inc. (NUAN) Delisted | Executive VP and GM Healthcare | 269,279 | $55.99 | $15.08M | -$2.23M | 24 | 2013-12-10 |
Recent Filings · Page 4 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-02-15 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2017-12-14 | CRMD | Buy (P) | +52,083 | $25.0K | EDGAR |
| 2017-11-16 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2017-08-24 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2017-05-17 | CRMD | Mixed | +21,231 | $10.1K | EDGAR |
| 2017-02-23 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2017-02-15 | CRMD | Buy (P) | — | $0 | EDGAR |
| 2016-11-16 | CRMD | Buy (P) | — | $0 | EDGAR |
| 2016-08-16 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2016-06-29 | CRMD | Buy (P) | +15,000 | $39.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.